329 related articles for article (PubMed ID: 24041138)
1. Prescription in patients with chronic heart failure and multimorbidity attended in primary care.
Frigola-Capell E; Verdú-Rotellar JM; Comin-Colet J; Davins-Miralles J; Hermosilla E; Wensing M; Suñol R
Qual Prim Care; 2013; 21(4):211-9. PubMed ID: 24041138
[TBL] [Abstract][Full Text] [Related]
2. Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003.
Lamb DA; Eurich DT; McAlister FA; Tsuyuki RT; Semchuk WM; Wilson TW; Blackburn DF
Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):228-35. PubMed ID: 20031842
[TBL] [Abstract][Full Text] [Related]
3. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
4. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
Cohen Solal A; Leurs I; Assyag P; Beauvais F; Clerson P; Contre C; Thebaut JF; Genoun M;
Arch Cardiovasc Dis; 2012; 105(6-7):355-65. PubMed ID: 22800720
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center.
Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M
Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic treatment in dialysis patients hospitalized for cardiovascular reasons: do we follow the guidelines?
Tomaszuk-Kazberuk A; Kozuch M; Malyszko J; Bachorzewska-Gajewska H; Dobrzycki S; Musial WJ
Ren Fail; 2013; 35(2):235-42. PubMed ID: 23176538
[TBL] [Abstract][Full Text] [Related]
7. Influence of hospitalisation on the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in elderly hypertensive patients.
Wawruch M; Slezakova V; Murin J; Luha J; Bozik M; Leitmann T; Kuzelova M; Shah R
Aging Clin Exp Res; 2014 Jun; 26(3):307-14. PubMed ID: 24781831
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project.
Schmedtje JF; Evans GW; Byerly W; King M; Goonan K; Blastock-Glenn C; Croft JB; Goff DC
N C Med J; 2003; 64(1):4-10. PubMed ID: 12774552
[TBL] [Abstract][Full Text] [Related]
9. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
Mayyas F; Bataineh W; Jarab A
Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
[TBL] [Abstract][Full Text] [Related]
10. A Modern History RAAS Inhibition and Beta Blockade for Heart Failure to Underscore the Non-equivalency of ACEIs and ARBs.
Hyman DA; Siebert VR; Birnbaum GD; Alam M; Birnbaum Y
Cardiovasc Drugs Ther; 2020 Apr; 34(2):215-221. PubMed ID: 32219664
[TBL] [Abstract][Full Text] [Related]
11. Risk-treatment mismatch in the pharmacotherapy of heart failure.
Lee DS; Tu JV; Juurlink DN; Alter DA; Ko DT; Austin PC; Chong A; Stukel TA; Levy D; Laupacis A
JAMA; 2005 Sep; 294(10):1240-7. PubMed ID: 16160132
[TBL] [Abstract][Full Text] [Related]
12. General practitioners' adherence to chronic heart failure guidelines regarding medication: the GP-HF study.
Hirt MN; Muttardi A; Helms TM; van den Bussche H; Eschenhagen T
Clin Res Cardiol; 2016 May; 105(5):441-50. PubMed ID: 26552905
[TBL] [Abstract][Full Text] [Related]
13. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker).
Dimopoulos K; Salukhe TV; Coats AJ; Mayet J; Piepoli M; Francis DP
Int J Cardiol; 2004 Feb; 93(2-3):105-11. PubMed ID: 14975535
[TBL] [Abstract][Full Text] [Related]
14. Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease.
Wang PT; Huang YB; Lin MY; Chuang PF; Hwang SJ
Kaohsiung J Med Sci; 2012 Sep; 28(9):477-83. PubMed ID: 22974666
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of the heart failure population in Poland: ZOPAN, a multicentre national programme.
Rywik TM; Kołodziej P; Targoński R; Fedyk-Łukasik M; Nowicka A; Zinka E; Zbyszyński B; Achremczyk P; Górski J; Muder A; Sadowski J; Leszek P; Kurjata P; Broda G; Korewicki J
Kardiol Pol; 2011; 69(1):24-31. PubMed ID: 21267960
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
Filippi A; D'Ambrosio G; Giustini SE; Pecchioli S; Mazzaglia G; Cricelli C
J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
[TBL] [Abstract][Full Text] [Related]
17. The care for chronic heart failure by general practitioners. Results from a clinical audit in Italy.
Cancian M; Battaggia A; Celebrano M; Del Zotti F; Novelletto BF; Michieli R; Saugo M; Pellizzari M; Toffanin R
Eur J Gen Pract; 2013 Mar; 19(1):3-10. PubMed ID: 22998169
[TBL] [Abstract][Full Text] [Related]
18. Heart failure patients receiving ACEIs/ARBs were less likely to be hospitalized or to use emergency care in the following year.
Chen JY; Kang N; Juarez DT; Yermilov I; Braithwaite RS; Hodges KA; Legorreta A; Chung RS
J Healthc Qual; 2011; 33(4):29-36. PubMed ID: 21733022
[TBL] [Abstract][Full Text] [Related]
19. Long-term trends of angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker use after heart failure hospitalization in community-dwelling seniors.
Setoguchi S; Levin R; Winkelmayer WC
Int J Cardiol; 2008 Apr; 125(2):172-7. PubMed ID: 17997175
[TBL] [Abstract][Full Text] [Related]
20. First hospitalization for heart failure in France in 2009: patient characteristics and 30-day follow-up.
Tuppin P; Cuerq A; de Peretti C; Fagot-Campagna A; Danchin N; Juillière Y; Alla F; Allemand H; Bauters C; Drici MD; Hagège A; Jondeau G; Jourdain P; Leizorovicz A; Paccaud F
Arch Cardiovasc Dis; 2013 Nov; 106(11):570-85. PubMed ID: 24140417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
